ABT Abbott Laboratories | US0028241000
Financials
Trends
Details
| Breakdown | 31.12.2027 | 31.12.2026 | Change % |
|---|---|---|---|
| Total Revenue | 54.629.072.250 | 50.286.457.600 | 8.64% |
| Cost of Revenue | -- | -- | -- |
| Gross Profit | -- | -- | -- |
| Operating Expense | -- | -- | -- |
| Selling General and Administrative | -- | -- | -- |
| Research & Development | -- | -- | -- |
| Operating Income | -- | -- | -- |
| Pretax Income | -- | -- | -- |
| Net Income Common Stockholders | -- | -- | -- |
| Basic EPS | 6,06 | 5,51 | 9.99% |
| Diluted EPS | -- | -- | -- |
| Analyst Count | 24 | 24 | 0.00% |
| EBIT | -- | -- | -- |
| EBITDA | -- | -- | -- |